Pnc Financial Services Group, Inc. My Md Pharmaceuticals, Inc. Call Options Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MYMD
# of Institutions
2Shares Held
30.2KCall Options Held
0Put Options Held
0About MyMD Pharmaceuticals, Inc.
- Ticker MYMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,470,000
- Market Cap $67.5M
- Description
- MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...